Sio Capital Management as of June 30, 2017
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 55 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quotient | 8.3 | $17M | 2.4M | 7.36 | |
| Johnson & Johnson (JNJ) | 4.4 | $9.3M | 70k | 132.29 | |
| Sanofi-Aventis SA (SNY) | 4.1 | $8.7M | 182k | 47.91 | |
| Intuitive Surgical (ISRG) | 4.1 | $8.6M | 9.2k | 935.33 | |
| Aetna | 3.8 | $7.9M | 52k | 151.83 | |
| Hca Holdings (HCA) | 3.8 | $7.9M | 90k | 87.21 | |
| Acorda Therapeutics | 3.6 | $7.5M | 380k | 19.70 | |
| Koninklijke Philips Electronics NV (PHG) | 3.5 | $7.3M | 205k | 35.82 | |
| Allergan | 3.5 | $7.3M | 30k | 243.10 | |
| Puma Biotechnology (PBYI) | 3.3 | $7.0M | 80k | 87.40 | |
| LifePoint Hospitals | 3.2 | $6.7M | 100k | 67.15 | |
| Thermo Fisher Scientific (TMO) | 3.0 | $6.3M | 36k | 174.48 | |
| Eli Lilly & Co. (LLY) | 2.9 | $6.0M | 74k | 82.31 | |
| Seattle Genetics | 2.5 | $5.2M | 100k | 51.74 | |
| Abbvie (ABBV) | 2.4 | $5.1M | 70k | 72.51 | |
| GlaxoSmithKline | 2.3 | $4.9M | 113k | 43.12 | |
| Sage Therapeutics (SAGE) | 2.3 | $4.8M | 60k | 79.63 | |
| Tabula Rasa Healthcare | 2.2 | $4.7M | 313k | 15.05 | |
| Insmed (INSM) | 2.2 | $4.6M | 267k | 17.16 | |
| Agios Pharmaceuticals (AGIO) | 2.0 | $4.3M | 83k | 51.44 | |
| Advanced Accelerat spon ads each rep 2 ord | 2.0 | $4.2M | 109k | 39.04 | |
| Halyard Health | 1.9 | $4.0M | 101k | 39.28 | |
| UnitedHealth (UNH) | 1.9 | $3.9M | 21k | 185.43 | |
| Globus Med Inc cl a (GMED) | 1.8 | $3.8M | 113k | 33.15 | |
| PerkinElmer (RVTY) | 1.8 | $3.7M | 54k | 68.15 | |
| Rigel Pharmaceuticals (RIGL) | 1.8 | $3.7M | 1.3M | 2.73 | |
| Regeneron Pharmaceuticals (REGN) | 1.6 | $3.4M | 7.0k | 491.14 | |
| Smith & Nephew (SNN) | 1.3 | $2.7M | 77k | 34.85 | |
| Medtronic (MDT) | 1.3 | $2.7M | 30k | 88.77 | |
| Anthem (ELV) | 1.2 | $2.6M | 14k | 188.13 | |
| Mazor Robotics Ltd. equities | 1.2 | $2.6M | 74k | 34.58 | |
| Natus Medical | 1.2 | $2.5M | 68k | 37.30 | |
| Nevro (NVRO) | 1.2 | $2.5M | 33k | 74.44 | |
| Luminex Corporation | 1.2 | $2.4M | 116k | 21.12 | |
| Endologix | 1.1 | $2.4M | 493k | 4.86 | |
| Chemocentryx | 1.1 | $2.3M | 245k | 9.36 | |
| Viewray (VRAYQ) | 1.0 | $2.0M | 314k | 6.47 | |
| Penumbra (PEN) | 0.8 | $1.8M | 20k | 87.75 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $1.7M | 60k | 27.88 | |
| Catalyst Biosciences | 0.8 | $1.6M | 353k | 4.65 | |
| Medifast (MED) | 0.8 | $1.6M | 39k | 41.48 | |
| Vocera Communications | 0.7 | $1.5M | 56k | 26.41 | |
| Zynerba Pharmaceuticals | 0.6 | $1.2M | 70k | 16.97 | |
| Clovis Oncology | 0.6 | $1.2M | 13k | 93.60 | |
| Arena Pharmaceuticals | 0.6 | $1.2M | 69k | 16.87 | |
| Steadymed | 0.5 | $1.1M | 168k | 6.30 | |
| Flamel Technologies Sa (AVDL) | 0.5 | $1.0M | 91k | 11.03 | |
| Axsome Therapeutics (AXSM) | 0.4 | $880k | 160k | 5.50 | |
| Axovant Sciences | 0.3 | $689k | 30k | 23.20 | |
| Foamix Pharmaceuticals | 0.3 | $646k | 139k | 4.64 | |
| Adamis Pharmaceuticals Corp Com Stk | 0.3 | $637k | 123k | 5.20 | |
| Aeglea Biotherapeutics | 0.2 | $499k | 130k | 3.85 | |
| Pfenex | 0.2 | $344k | 86k | 4.01 | |
| Oasmia Pharmaceutical Ab | 0.1 | $213k | 203k | 1.05 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $91k | 34k | 2.70 |
